Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
drug used toinhibit lipoprotein -associatedphospholipase A2.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word darapladib.
Examples
-
The study will determine whether the as-yet unapproved drug called darapladib can reduce the risk of having a heart attack or stroke in people who already have heart disease.
-
Another, darapladib, is a cardiovascular drug currently being tested in 27,000 patients.
Glaxo Looks for Gene-Research Payoff on Other Drugs Jeanne Whalen 2011
-
Geisinger Health System in Danville, Pa., is one of more than 600 medical centers around the world participating in a GlaxoSmithKline PLC-funded trial of a new drug, darapladib, which aims to lower the risk of heart attacks and strokes in people with coronary heart disease by blocking an enzyme known as Lp-PLA2.
Making Clinical Trials Less of a Tribulation Jennifer Corbett Dooren 2011
-
If darapladib is shown to reduce a person's risk for having a heart attack or stroke, it could mark a significant medical advancement.
Glaxo Looks for Gene-Research Payoff on Other Drugs Jeanne Whalen 2011
-
The one-year trial of 330 patients -- presented at the European Society of Cardiology meeting in Munich -- showed darapladib can reduce levels of an enzyme linked to the buildup of plaques inside arteries.
-
U. K.-based GlaxoSmithKline PLC said experimental drug darapladib has shown promise in the treatment of fat plaque buildup inside blood vessels despite failing to meet its main goal in a midstage study.
-
Patrick Vallance, Glaxo's drug discovery senior vice president, said darapladib is an important part of the company's pipeline.
-
GlaxoSmithKline plc's Phase III product candidate, darapladib.
Boston Business News - Local Boston News | Boston Business Journal 2010
-
GlaxoSmithKline plc's Phase III product candidate, darapladib.
San Antonio Business News - Local San Antonio News | The San Antonio Business Journal 2010
-
GlaxoSmithKline plc's Phase III product candidate, darapladib.
San Antonio Business News - Local San Antonio News | The San Antonio Business Journal 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.